Bone density and body composition in children with growth hormone insensitivity syndrome receiving recombinant IGF-I

Summary objective There are few reports of the metabolic action of insulin‐like growth factor 1 (IGF‐I) in vivo. Growth hormone insensitivity syndrome is a good model to examine the effects of IGF‐I deficiency. This study was designed to assess body composition and bone density in children with gro...

Full description

Saved in:

Bibliographic Details
Published in:	Clinical endocrinology (Oxford) Vol. 59; no. 4; pp. 487 - 491
Main Authors:	Shaw, N. J., Fraser, N. C., Rose, S., Crabtree, N. J., Boivin, C. M.
Format:	Journal Article
Language:	English
Published:	Oxford, UK Blackwell Science Ltd 01-10-2003 Blackwell Wiley Subscription Services, Inc
Subjects:	Absorptiometry, Photon Adipose Tissue - drug effects Biological and medical sciences Body Composition - drug effects Body Height - drug effects Bone Density - drug effects Child Endocrinopathies Fundamental and applied biological sciences. Psychology Growth Disorders - drug therapy Growth Disorders - physiopathology Humans Insulin-Like Growth Factor I - deficiency Insulin-Like Growth Factor I - therapeutic use Longitudinal Studies Male Medical sciences Prospective Studies Recombinant Proteins - therapeutic use Skinfold Thickness Syndrome Vertebrates: endocrinology Human Osteoarticular system Laron dwarfism Bone Recombinant protein Insulin like growth factor 1 Density Child Body composition Endocrinology
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!